Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL (1985) The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 64(4):270–283
Bertherat J, Horvath A, Groussin L, Grabar S, Boikos S, Cazabat L, Libe R, Rene-Corail F, Stergiopoulos S, Bourdeau I et al (2009) Mutations in regulatory subunit type 1 A of cyclic adenosine 5‑monophosphate-dependent protein kinase (PRKAR1 A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab 94:2085–2091
Correa R, Salpea P, Stratakis CA (2015) Carney complex: an update. Eur J Endocrinol 173(4):M85–M97
Mateus C, Palangie A, Franck N, Groussin L, Bertagna X, Avril MF, Dupin N, Bertherat J (2008) Heterogeneity of skin manifestations in patients with Carney complex. J Am Acad Dermatol 59:801–810
Louiset E, Stratakis CA, Perraudin V, Griffin KJ, Libe R, Cabrol S, Feve B, Young J, Groussin L, Bertherat J et al (2009) The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor mediated effect of dexamethasone on protein kinase A catalytic subunits. J Clin Endocrinol Metab 94:2406–2413
Stratakis CA, Kirschner LS, Carney JA (2001) Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 86(9):4041–4046
Courcoutsakis NA, Tatsi C, Patronas NJ, Lee CC, Prassopoulos PK, Stratakis CA (2013) The complex of myxomas, spotty skin pigmentation and endocrine overactivity (Carney complex): imaging findings with clinical and pathological correlation. Insights Imaging 4:119–133
Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA (2000) Mutations of the gene encoding the protein kinase A type I‑α regulatory subunit in patients with the Carney Complex. Nat Genet 26:89–92